MX2012002091A - Uso de antibioticos en aerosol para el tratamiento de la enfermedad pulmonar obstructiva cronica. - Google Patents
Uso de antibioticos en aerosol para el tratamiento de la enfermedad pulmonar obstructiva cronica.Info
- Publication number
- MX2012002091A MX2012002091A MX2012002091A MX2012002091A MX2012002091A MX 2012002091 A MX2012002091 A MX 2012002091A MX 2012002091 A MX2012002091 A MX 2012002091A MX 2012002091 A MX2012002091 A MX 2012002091A MX 2012002091 A MX2012002091 A MX 2012002091A
- Authority
- MX
- Mexico
- Prior art keywords
- obstructive pulmonary
- chronic obstructive
- pulmonary disease
- treating chronic
- aerosolized antibiotics
- Prior art date
Links
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 208000019693 Lung disease Diseases 0.000 abstract 3
- 230000000414 obstructive effect Effects 0.000 abstract 3
- 206010006458 Bronchitis chronic Diseases 0.000 abstract 2
- 206010006451 bronchitis Diseases 0.000 abstract 2
- 208000007451 chronic bronchitis Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a métodos y composiciones para tratar trastornos pulmonares obstructivos. En particular, las composiciones y métodos descritos en la presente se refieren al uso de un antibiótico en aerosol para tratar trastornos pulmonares obstructivos que incluyen el trastorno pulmonar obstructivo crónico (EPOC) y la bronquitis crónica (BC).
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23531909P | 2009-08-19 | 2009-08-19 | |
US24074909P | 2009-09-09 | 2009-09-09 | |
US24922809P | 2009-10-06 | 2009-10-06 | |
PCT/US2010/002307 WO2011022075A1 (en) | 2009-08-19 | 2010-08-19 | Use of aerosolized antibiotics for treating chronic obstructive pulmonary disease |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2012002091A true MX2012002091A (es) | 2012-07-03 |
Family
ID=43607264
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012002091A MX2012002091A (es) | 2009-08-19 | 2010-08-19 | Uso de antibioticos en aerosol para el tratamiento de la enfermedad pulmonar obstructiva cronica. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20120237564A1 (es) |
EP (1) | EP2467138A4 (es) |
JP (1) | JP2013502416A (es) |
KR (1) | KR20120103561A (es) |
CN (1) | CN102711760A (es) |
AU (1) | AU2010284678A1 (es) |
BR (1) | BR112012003453A2 (es) |
CA (1) | CA2770355A1 (es) |
CL (1) | CL2012000428A1 (es) |
IL (1) | IL218148A0 (es) |
MX (1) | MX2012002091A (es) |
RU (1) | RU2012108962A (es) |
WO (1) | WO2011022075A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8524735B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
CA2739893C (en) | 2008-10-07 | 2016-10-04 | Mpex Pharmaceuticals, Inc. | Inhalation of levofloxacin for reducing lung inflammation |
AU2009302478B2 (en) | 2008-10-07 | 2015-09-03 | Horizon Orphan Llc | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
MX353288B (es) | 2009-09-04 | 2018-01-08 | Raptor Pharmaceuticals Inc | Uso de levofloxacina aerosolizada para el tratamiento de fibrosis quistica. |
CN105555364A (zh) * | 2013-04-09 | 2016-05-04 | 克雷瑟特分子学探索有限公司 | 炎症性眼科疾病的局部治疗 |
EA202190567A1 (ru) * | 2018-08-22 | 2021-05-26 | Авалин Фарма Инк. | Специальные комбинированные композиции ингаляционного нинтеданиба и солей нинтеданиба |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7838532B2 (en) * | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
LT1901749T (lt) * | 2005-05-18 | 2016-10-25 | Raptor Pharmaceuticals Inc. | Aerozoliniai fluorchinolinai ir jų naudojimas |
PT1991201T (pt) * | 2006-02-10 | 2018-06-12 | Pari Pharma Gmbh | Antibióticos nebulizados para terapia de inalação |
CA2739893C (en) * | 2008-10-07 | 2016-10-04 | Mpex Pharmaceuticals, Inc. | Inhalation of levofloxacin for reducing lung inflammation |
AU2009302478B2 (en) * | 2008-10-07 | 2015-09-03 | Horizon Orphan Llc | Aerosol fluoroquinolone formulations for improved pharmacokinetics |
-
2010
- 2010-08-19 RU RU2012108962/15A patent/RU2012108962A/ru not_active Application Discontinuation
- 2010-08-19 CN CN2010800416695A patent/CN102711760A/zh active Pending
- 2010-08-19 MX MX2012002091A patent/MX2012002091A/es not_active Application Discontinuation
- 2010-08-19 WO PCT/US2010/002307 patent/WO2011022075A1/en active Application Filing
- 2010-08-19 EP EP10810291.4A patent/EP2467138A4/en not_active Withdrawn
- 2010-08-19 JP JP2012525534A patent/JP2013502416A/ja active Pending
- 2010-08-19 CA CA2770355A patent/CA2770355A1/en not_active Abandoned
- 2010-08-19 AU AU2010284678A patent/AU2010284678A1/en not_active Abandoned
- 2010-08-19 BR BR112012003453A patent/BR112012003453A2/pt not_active IP Right Cessation
- 2010-08-19 KR KR1020127006930A patent/KR20120103561A/ko not_active Application Discontinuation
-
2012
- 2012-02-16 US US13/398,310 patent/US20120237564A1/en not_active Abandoned
- 2012-02-16 IL IL218148A patent/IL218148A0/en unknown
- 2012-02-17 CL CL2012000428A patent/CL2012000428A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2467138A4 (en) | 2013-11-06 |
RU2012108962A (ru) | 2013-09-27 |
KR20120103561A (ko) | 2012-09-19 |
BR112012003453A2 (pt) | 2019-09-24 |
CA2770355A1 (en) | 2011-02-24 |
CN102711760A (zh) | 2012-10-03 |
US20120237564A1 (en) | 2012-09-20 |
AU2010284678A1 (en) | 2012-02-23 |
IL218148A0 (en) | 2012-06-28 |
CL2012000428A1 (es) | 2012-09-28 |
WO2011022075A1 (en) | 2011-02-24 |
EP2467138A1 (en) | 2012-06-27 |
JP2013502416A (ja) | 2013-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018236800B2 (en) | DNA-PK inhibitors | |
WO2011158042A3 (en) | Ureido- pyrazole derivatives for use in the treatment of rhinovirus infections | |
EP4036240A3 (en) | Transduction buffer | |
MX2012002091A (es) | Uso de antibioticos en aerosol para el tratamiento de la enfermedad pulmonar obstructiva cronica. | |
AU2016219704A1 (en) | Anti-Notch1 antibodies | |
MX2015006681A (es) | Formulaciones de vancomicina estabilizadas. | |
WO2010151797A3 (en) | Compounds for modulating rna binding proteins and uses therefor | |
MX2009001981A (es) | Compuesto que contiene sulfato de bario. | |
UA115983C2 (uk) | Інгібітори днк-пк | |
WO2012174487A8 (en) | Bromodomain inhibitors and uses thereof | |
SG179085A1 (en) | Pi3 kinase inhibitors and uses thereof | |
WO2012151512A3 (en) | Bromodomain inhibitors and uses thereof | |
TN2011000414A1 (en) | Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitors, and uses thereof | |
UA105033C2 (uk) | Фармацевтична композиція, що включає глюкопіранозилзаміщене похідне бензолу, фармацевтична дозована форма, що містить зазначене похідне, їх застосування для лікування метаболічного порушення | |
HK1203044A1 (en) | Compositions comprising necrosis inhibitors, such as necrostatins, alone or in combination, for promoting axon regeneration and nerve function, thereby treating cns disorders cns | |
GEP20186885B (en) | Novel compounds | |
UA105073C2 (uk) | Антитіло проти фракталкіну, композиція і спосіб для лікування запальних порушень | |
ZA201109492B (en) | Compositions comprising finafloxacin and methods for treating ophthalmic,otic,or nasal infections | |
WO2009092052A3 (en) | Methods and compositions for treating polyps | |
CA2843611C (en) | Compositions and methods for reducing the incidence of equine digestive disorders | |
MX2015000179A (es) | Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas. | |
PH12014502351B1 (en) | Methods of producing anamorelin hydrochloride having controlled chloride content | |
WO2014182928A3 (en) | Stat6 inhibitors | |
WO2013066802A3 (en) | Compositions and methods for lung regeneration | |
WO2013016332A3 (en) | Composition and method for treating migraines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |